Data from EMC - Curated by Toby Galbraith - Last updated 19 October 2016

Indication(s)

Actelsar HCT 40 mg/12.5 mg tablets:
Treatment of essential hypertension.

Actelsar HCT fixed dose combination (40 mg telmisartan/12.5 mg hydrochlorothiazide) is indicated in adults whose blood pressure is not adequately controlled on telmisartan alone.


Actelsar HCT 80 mg/12.5 mg tablets:
Treatment of essential hypertension.

Actelsar HCT fixed dose combination (80 mg telmisartan/12.5 mg hydrochlorothiazide) is indicated in adults whose blood pressure is not adequately controlled on telmisartan alone.


Actelsar HCT 80 mg/25 mg tablets:
Treatment of essential hypertension.

Actelsar HCT fixed dose combination (80 mg telmisartan/25 mg hydrochlorothiazide) is indicated in adults whose blood pressure is not adequately controlled on Actelsar HCT 80 mg/12.5 mg (80 mg telmisartan/12.5 mg hydrochlorothiazide) or adults who have been previously stabilised on telmisartan and hydrochlorothiazide given separately.

 

Full Prescribing information

Learning Zones

An epgonline.org Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

Bedwetting

Essential screening, diagnosis and best strategies to manage bedwetting

Visit Bedwetting

Prostate Cancer

How can you balance the harmful effects of treatment with control of prostate cancer growth in otherwise healthy patients?

Visit Prostate Cancer

More information

Category Value
Orphan designation No
Type POM
Marketing authorisation holder Actavis Group hf

Related Content